These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1636501)

  • 1. Interactions of phospholipids and free fatty acids with antidepressant recognition binding sites in rat brain.
    Stockert M; Zieher LM; Medina JH
    Adv Exp Med Biol; 1992; 318():325-30. PubMed ID: 1636501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase A2 and 3H-hemicholinium-3 binding sites in rat brain: a potential second-messenger role for fatty acids in the regulation of high-affinity choline uptake.
    Saltarelli MD; Yamada K; Coyle JT
    J Neurosci; 1990 Jan; 10(1):62-72. PubMed ID: 2299401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 3H-quinuclidinyl benzylate binding to cardiac muscarinic receptor by long chain fatty acids can be attenuated by ligand occupation of the receptor.
    Rauch B; Colvin RA; Messineo FC
    J Mol Cell Cardiol; 1989 May; 21(5):495-506. PubMed ID: 2778805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of gamma-aminobutyric acid/barbiturate receptor-gated chloride ion flux in brain vesicles by phospholipase A2: possible role of oxygen radicals.
    Schwartz RD; Skolnick P; Paul SM
    J Neurochem; 1988 Feb; 50(2):565-71. PubMed ID: 2447244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo action of phosphatidylserine, amitriptyline and stress on the binding of [3H]imipramine to membranes of the rat cerebral cortex.
    Stockert M; Buscaglia V; De Robertis E
    Eur J Pharmacol; 1989 Jan; 160(1):11-6. PubMed ID: 2714356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down regulation of cerebral cortical 3H imipramine binding sites during chronic antidepressant treatment is independent of the central serotonergic innervation.
    Stockert M; Silveira R; Zieher LM; Dajas F; Medina JH
    J Recept Res; 1992; 12(2):131-47. PubMed ID: 1583619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effects of phosphatidylserine on the binding of muscarinic cholinergic receptor ligands. Studies in vitro and in vivo.
    Raskovsky S; Rivas E; Bernik D; Medina J; Jerusalinsky D
    Mol Chem Neuropathol; 1990; 13(1-2):17-32. PubMed ID: 2095782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptically acting snake venom phospholipase A2 enzymes attack unique substrates.
    Fletcher JE; Jiang MS
    Toxicon; 1995 Dec; 33(12):1565-76. PubMed ID: 8866614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre- and postsynaptic localization of 3H-imipramine binding sites in rat cerebral cortex.
    Stockert M; Veiga A; Butman S; De Robertis E
    J Recept Res; 1984; 4(7):755-71. PubMed ID: 6527359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Na+,K+-ATPase activity by phospholipase A2 and several lysophospholipids: possible role of phospholipase A2 in noradrenaline release from cerebral cortical synaptosomes.
    Nishikawa T; Tomori Y; Yamashita S; Shimizu S
    J Pharm Pharmacol; 1989 Jul; 41(7):450-8. PubMed ID: 2570849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phospholipase A2 on temperature-induced high-affinity [3H]tryptamine binding sites in rat brain.
    Saito M; Serikyaku S; Ishitani R
    Jpn J Pharmacol; 1991 Aug; 56(4):413-9. PubMed ID: 1744985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of [35S]-ATP alpha S and [3H]-alpha, beta-MeATP binding sites in rat brain cortical synaptosomes: regulation of ligand binding by divalent cations.
    Schäfer R; Reiser G
    Br J Pharmacol; 1997 Jul; 121(5):913-22. PubMed ID: 9222547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro modulation of central type benzodiazepine receptors by phosphatidylserine.
    Levi de Stein M; Medina JH; De Robertis E
    Brain Res Mol Brain Res; 1989 Jan; 5(1):9-15. PubMed ID: 2538706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of ligand binding to membranes by a soluble acceptor. Alpha-1-acid glycoprotein attenuates 3H-imipramine binding to cerebral membranes.
    Barkai AI; Baron M; Kowalik S; Cooper TB
    Biol Psychiatry; 1986 Aug; 21(10):883-8. PubMed ID: 2427130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate.
    Diez E; Chilton FH; Stroup G; Mayer RJ; Winkler JD; Fonteh AN
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):721-6. PubMed ID: 8053897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid-eye-movement sleep deprivation decreases the density of 3H-dihydroalprenolol and 3H-imipramine binding sites in the rat cerebral cortex.
    Mogilnicka E; Arbilla S; Depoortere H; Langer SZ
    Eur J Pharmacol; 1980 Jul; 65(2-3):289-92. PubMed ID: 7398791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipid hydrolysis and loss of membrane integrity following treatment of rat brain synaptosomes with beta-bungarotoxin, notexin, and Naja naja atra and Naja nigricollis phospholipase A2.
    Yates SL; Burns M; Condrea E; Ghassemi A; Shina R; Rosenberg P
    Toxicon; 1990; 28(8):939-51. PubMed ID: 2080518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of exogenous phospholipase A2 treatment on cardiac muscarinic receptors of highly purified canine sarcolemmal vesicles.
    Rauch B; Colvin RA; Katz AM; Messineo FC
    J Mol Cell Cardiol; 1987 Jun; 19(6):569-80. PubMed ID: 3625786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antidepressants on the phospholipase A2 activity in plasma membranes of the rat brain cortex.
    Kucia K; Małecki A; Gabryel B; Trzeciak HI
    Pol J Pharmacol; 2003; 55(1):5-15. PubMed ID: 12856820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High- and low-affinity [3H]imipramine binding sites on human platelets: separate determination and involvement of sulphur-containing bonds.
    Demushkin VP; Fomenko AM; Plyashkevich YG; Shchurin MR; Brusov OS
    Eur J Pharmacol; 1987 Aug; 140(2):171-8. PubMed ID: 2822438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.